» Articles » PMID: 29020263

2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV

Overview
Journal Clin Infect Dis
Date 2017 Oct 12
PMID 29020263
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Pain has always been an important part of human immunodeficiency virus (HIV) disease and its experience for patients. In this guideline, we review the types of chronic pain commonly seen among persons living with HIV (PLWH) and review the limited evidence base for treatment of chronic noncancer pain in this population. We also review the management of chronic pain in special populations of PLWH, including persons with substance use and mental health disorders. Finally, a general review of possible pharmacokinetic interactions is included to assist the HIV clinician in the treatment of chronic pain in this population.It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The Infectious Diseases Society of American considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Citing Articles

Opioid risk-reduction strategies for people with HIV on chronic opioid therapy: A qualitative study of patient perspectives.

Lunze K, Carroll J, Ahuja N, Lira M, Tsui J, Ventura A SSM Ment Health. 2025; 6.

PMID: 39990723 PMC: 11845234. DOI: 10.1016/j.ssmmh.2024.100364.


Pain Severity and Experiences with Pain Management Predict Alcohol Use Among Men Who Have Sex with Men Living with HIV.

Ferguson E, Pantalone D, Monti P, Mayer K, Kahler C AIDS Behav. 2025; .

PMID: 39928074 DOI: 10.1007/s10461-025-04652-8.


Chronic Pain, Mental Health, and Sense of Purpose in Life Among Women Living with HIV Compared to HIV-Negative Women in the British Columbia CARMA-CHIWOS Collaboration (BCC3) Study.

Ragazan D, Povshedna T, Tognazzini S, Kaida A, Murray M, Cote H AIDS Behav. 2025; .

PMID: 39890757 DOI: 10.1007/s10461-025-04644-8.


Role of the pharmacist caring for people at risk of or living with HIV in Canada.

Tkachuk S, Ready E, Chan S, Hawkes J, Janzen Cheney T, Kapler J Can Pharm J (Ott). 2024; 157(5):218-239.

PMID: 39310805 PMC: 11412478. DOI: 10.1177/17151635241267350.


Priorities for HIV and chronic pain research: results from a survey of individuals with lived experience.

Robinson-Papp J, Lawrence S, Wadley A, Scott W, George M, Josh J AIDS Care. 2024; :1-11.

PMID: 38588701 PMC: 11458822. DOI: 10.1080/09540121.2024.2334358.


References
1.
Michna E, Ross E, Hynes W, Nedeljkovic S, Soumekh S, Janfaza D . Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history. J Pain Symptom Manage. 2004; 28(3):250-8. DOI: 10.1016/j.jpainsymman.2004.04.007. View

2.
Kieburtz K, Simpson D, Yiannoutsos C, Max M, HALL C, Ellis R . A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998; 51(6):1682-8. DOI: 10.1212/wnl.51.6.1682. View

3.
Saber-Tehrani A, Bruce R, Altice F . Pharmacokinetic drug interactions and adverse consequences between psychotropic medications and pharmacotherapy for the treatment of opioid dependence. Am J Drug Alcohol Abuse. 2011; 37(1):1-11. DOI: 10.3109/00952990.2010.540279. View

4.
Pollini R, McCall L, Mehta S, Vlahov D, Strathdee S . Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2005; 83(2):104-10. PMC: 3711523. DOI: 10.1016/j.drugalcdep.2005.10.015. View

5.
Simpson D, Brown S, Tobias J, Vanhove G . NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study. Clin J Pain. 2013; 30(2):134-42. DOI: 10.1097/AJP.0b013e318287a32f. View